Te Rārangi Rongoā Pharmaceutical Schedule
Pharmaceutical Schedule

All funded medicines in New Zealand.
Te pūtea me ngā umanga rongoā Medicine funding and supply
Medicine funding and supply

Ask us to fund a medicine | Check changes to medicines | How do generics work?
- Make an application
- Medicine notices (includes supply issues)
  
  Brand changes, discontinuations and more.
- The funding process
- What you need to know about medicines
- Medicine supply management
  
  Order condoms and nicotine replacement | About supply management
Ngā pūrere hauora a te hōhipere Hospital medical devices
Hospital medical devices

PHARMAC contracts with device suppliers to ensure our hospitals can buy medical devices at fairer prices.
- Devices Schedule
  
  Download the latest hospital medical devices schedule
- Category Information
  
  Medical devices we have contracted and the ones we're working on
- Growing our role in medical devices
- Device Advice
  
  Read and subscribe to our devices newsletter
Treaty of Waitangi Te Tiriti o Waitangi
Te Tiriti o Waitangi
- Te Whaioranga
  
  PHARMAC's Māori Responsiveness Strategy
- Hauora Arotahi
  
  The Māori health areas of focus
- Programmes to support Māori health
  
  Scholarships, awards and programmes
- How we work with Whānau Ora
Ngā karere me ngā rauemi News and resources
News and resources
- Consultations and decisions
  
  includes RFPs and tenders.
- News and updates
- Order publications
- Seminars
- Covid-19
- Pharmac's research
- Uptake of medicines for type 2 diabetes
  
  Over 40,000 approved Special Authority applications.
Mō About
About
- Strategic Direction
  
  Our plan to deliver the best health outcomes for New Zealanders
- Pacific Responsiveness Strategy
- Te Tiriti o Waitangi
- What we do
- Who we are
- How we get expert advice
  
  Advice we seek to make decisions
- Working at Pharmac
  
  Explore current vacancies
- Contact us
  
  How to get in touch

Oxycodone hydrochloride tabs controlled-release 5 mg: Supply issue resolved

Last Updated: 9 March 2021

We understand that the supplier has released the New Zealand-registered product for supply.

Sandoz has resupplied the NZ-registered product. There was no out of stock at the consumer level.

Sandoz had prepared a s29 alternative in case the product didn't arrive in time. We listed it in the Pharmaceutical Schedule in case it was needed (details below).

Who to contact

If you have any questions about this supply issue, contact Sandoz:

phone: 0800 354 335
email: medical.information@sandoz.com

If you have any questions about funding of these medicines, contact enquiry@pharmac.govt.nz

Details of alternative product sourced

Alternative product sourced

The supplier had sourced stock of an alternative Australian-registered product to cover the potential out of stock of the funded product. However this product was not required as the NZ registered product arrived before the supply issue reached patients.

We listed the alternative on the Pharmaceutical Schedule.

Chemical: Oxycodone hydrochloride
Brand: Oxycodone Sandoz s29
Presentation: Tab controlled-release 5 mg
Pharmacode: 2605643